Laser versus Anti-VEGF: A Paradigm Shift for Treatment-Warranted Retinopathy of Prematurity is a research paper published in Ophthalmology and Therapy (2023). On theSindex it has a DataRank of 0. It has been cited 33 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Research to Prevent Blindness
Grant: unrestricted
National Eye Institute
Grant: R01 EY015130
National Eye Institute
Grant: R01 EY017011
National Institutes of Health
Grant: 2R01EY015130-06
Mechanisms of Angiogenesis of Retinopathy of Prematurity
National Institutes of Health
Grant: 2R01EY017011-07
Endothelial Transmigration in Neovascular Age-related Macular Degeneration
National Institutes of Health
Grant: 1R21EY033579-01
A Phase 2 Study of the Value of Pre-symptomatic Genetic Risk Assessment for Age-Related Macular Degeneration
Novartis Pharma
Pharmaceuticals Bayer
FWCI
5.40
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals